OPPM
REGN icon

Opus Point Partners Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Opus Point Partners Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$677K Buy
2,439
+218
+10% +$64.5K 1.22% 18
2019
Q2 		$695K Buy
2,221
+20
+0.9% +$6.66K 1.03% 23
2019
Q1 		$904K Sell
2,201
-315
-13% -$130K 1.23% 18
2018
Q4 		$940K Sell
2,516
-15
-0.6% -$5.49K 2.07% 13
2018
Q3 		$1.02M Sell
2,531
-167
-6% -$63.6K 2.44% 18
2018
Q2 		$931K Buy
2,698
+76
+3% +$23.8K 2.02% 21
2018
Q1 		$903K Sell
2,622
-1,454
-36% -$506K 1.77% 19
2017
Q4 		$1.53M Sell
4,076
-485
-11% -$196K 1.33% 26
2017
Q3 		$2.04M Buy
4,561
+29
+0.6% +$13.8K 1.83% 25
2017
Q2 		$2.23M Sell
4,532
-3,503
-44% -$1.53M 2.04% 19
2017
Q1 		$3.11M Buy
8,035
+351
+5% +$130K 2.31% 23
2016
Q4 		$2.82M Buy
7,684
+172
+2% +$65.4K 2.25% 19
2016
Q3 		$3.02M Buy
7,512
+279
+4% +$112K 1.69% 19
2016
Q2 		$2.53M Sell
7,233
-1,696
-19% -$653K 2.44% 17
2016
Q1 		$3.22M Sell
8,929
-1,785
-17% -$736K 2.49% 19
2015
Q4 		$5.82M Buy
10,714
+87
+0.8% +$47.1K 3.84% 6
2015
Q3 		$4.94M Buy
10,627
+1,868
+21% +$1M 2.73% 11
2015
Q2 		$4.47M Buy
8,759
+9
+0.1% +$4.39K 3.54% 10
2015
Q1 		$3.95M Buy
8,750
+100
+1% +$42.4K 3.31% 7
2014
Q4 		$3.55M Buy
+8,650
New +$3.4M 3.51% 7

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return

Opus Point Partners Management's REGN Position: Q3 2019 in Review

Opus Point Partners Management increased its Regeneron Pharmaceuticals (REGN) stake by 9.8% in Q3 2019, buying an estimated $64.5K and bringing the position to 2,439 shares worth $677K. The position accounts for 1.22% of the portfolio, ranked #18.

Opus Point Partners Management first reported a position in REGN in Q4 2014 and has held it in 20 quarters since. The position peaked at $5.82M in Q4 2015. 633 funds tracked by Wall St. Rank hold REGN as of Q3 2019.

  • Opus Point Partners Management held 2,439 shares of Regeneron Pharmaceuticals worth $677K as of Q3 2019.
  • Opus Point Partners Management bought 218 Regeneron Pharmaceuticals shares in Q3 2019, an estimated $64.5K.
  • Regeneron Pharmaceuticals made up 1.22% of Opus Point Partners Management's portfolio in Q3 2019, its #18 holding.
  • Opus Point Partners Management first reported a position in Regeneron Pharmaceuticals in Q4 2014 and has held it in 20 quarters since.
  • Opus Point Partners Management's Regeneron Pharmaceuticals position peaked at $5.82M in Q4 2015.
  • 633 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2019.

Based on Opus Point Partners Management's 13F filing for Q3 2019, filed 14 Nov 2019.